TD2 Receives Three-Year Renewal of AAALAC Accreditation

July 18, 2018

We’re pleased to announce that our preclinical laboratory has again earned a Full Accreditation from AAALAC International Council.

TD2 has held AAALAC accreditation since 2010, and we’re thrilled that the 2018 renewal continues that succession through 2021.

In their letter of notification, the AAALAC Council on Accreditation made special recognitions of the following features of our preclinical facility, staff and resources:

– Our administrative commitment to the program, along with the caliber of our documentation throughout it.

– The engagement of our Institutional Animal Care and Use Committee.

– The level of sanitation, cleanliness and organization in our facility.

– Our Occupational Health & Safety signage.

– Our tumor monitoring guideline.

– Our heating, ventilation and air conditioning monitoring system.

– Our storage and documentation practices for controlled substances.

We’re proud to support humane and responsible animal treatment throughout all ends of our scientific research, and we’re honored to continue this voluntary accreditation for years to come.

Want to learn more about our AAALAC-accredited preclinical lab? Ask us for a tour!

Top Trends in ADC Drug Development

Antibody drug conjugates (ADCs) represent a significant advancement in cancer therapy, combining monoclonal antibodies with potent chemotherapeutic ...

Read more +

Unlocking Insights: Top 5 Reasons to Incorporate Orthotopic GBM PDX Models into Your Preclinical Evaluation

In the landscape of glioblastoma multiforme (GBM) research, the utilization of Orthotopic GBM Patient-Derived Xenograft (PDX) models stands as a ...

Read more +

The Vital Role of Highly Characterized Glioblastoma PDX Models in Preclinical Cancer Research: Insights from TD2's Most Recent Studies

The fight against Glioblastoma multiforme (GBM), one of the most aggressive forms of brain cancer, hinges on the development and use of advanced ...

Read more +

Get Started

Contact Us Today!

If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.